ATE222764T1 - Hydroxyomeprazol-enthaltende zubereitungen und verwendungen - Google Patents

Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Info

Publication number
ATE222764T1
ATE222764T1 AT99922802T AT99922802T ATE222764T1 AT E222764 T1 ATE222764 T1 AT E222764T1 AT 99922802 T AT99922802 T AT 99922802T AT 99922802 T AT99922802 T AT 99922802T AT E222764 T1 ATE222764 T1 AT E222764T1
Authority
AT
Austria
Prior art keywords
hydroxyomeprazole
omeprazole
treatment
containing preparations
drug
Prior art date
Application number
AT99922802T
Other languages
German (de)
English (en)
Inventor
William E Yelle
Dean A Handley
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ATE222764T1 publication Critical patent/ATE222764T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99922802T 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen ATE222764T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8425898P 1998-05-05 1998-05-05
PCT/US1999/009814 WO1999056746A1 (en) 1998-05-05 1999-05-05 Hydroxyomeprazole compositions and uses

Publications (1)

Publication Number Publication Date
ATE222764T1 true ATE222764T1 (de) 2002-09-15

Family

ID=22183810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922802T ATE222764T1 (de) 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Country Status (9)

Country Link
US (2) US6294586B1 (enExample)
EP (1) EP1082114B1 (enExample)
JP (1) JP2003517434A (enExample)
AT (1) ATE222764T1 (enExample)
AU (1) AU748872B2 (enExample)
CA (1) CA2330049A1 (enExample)
DE (1) DE69902657T2 (enExample)
ES (1) ES2182524T3 (enExample)
WO (1) WO1999056746A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420435B1 (en) * 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
JP2006516562A (ja) * 2003-01-24 2006-07-06 ステート オブ イスラエル、ミニストリー オブ アグリカルチャー 抗酸化活性を増強するための相乗的な組成物及び方法
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.

Also Published As

Publication number Publication date
CA2330049A1 (en) 1999-11-11
DE69902657D1 (de) 2002-10-02
EP1082114B1 (en) 2002-08-28
AU748872B2 (en) 2002-06-13
US6498171B2 (en) 2002-12-24
AU3971699A (en) 1999-11-23
JP2003517434A (ja) 2003-05-27
WO1999056746A1 (en) 1999-11-11
US6294586B1 (en) 2001-09-25
DE69902657T2 (de) 2003-04-30
ES2182524T3 (es) 2003-03-01
EP1082114A1 (en) 2001-03-14
US20020010196A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
HUP9702035A2 (hu) Leukocitaadhéziót gátló és VLA-4-antagonista vegyületek, valamint e vegyületeket tartalmazó gyógyászati készítmények
DE60039327D1 (de) Thermische Behandlung von Halbleitersubstraten
HUP9702034A2 (hu) Leukocitaadhéziót gátló és VLA-4-antagonista vegyületek valamint e vegyületeket tartalmazó gyógyászati készítmények
TR200101858T2 (tr) JNK protein kinaz inhibitörleri olarak 4-ariloksindoller
NO20061736L (no) Krystallform av epotilon B
NO933999L (no) Fibrinogenreseptorantagonister
NO20013770D0 (no) Metoder og blandinger for å öke antall hvite blodceller
DK0699192T3 (da) Substituerede oxazolylforbindelser til behandling af inflammation
BR0111451A (pt) Inibidores de serina protease
ATE461237T1 (de) Konjugierte copolymere aus dithienothiophen und vinylen oder acetylen
DE60011515D1 (de) Herstellung von Keramiksubstraten und ungesintertes Keramiksubstrat
TR200000059T2 (tr) Piridin türevleri
DE60042401D1 (de) Fab-i inhibitoren
DE60224957D1 (de) Harzzusammensetzung zur Einkapselung von Halbleitern und diese enthaltende Halbleiteranordnungen
WO2005099312A3 (en) Triarylamine compounds for use as charge transport materials
DE60209990D1 (de) Stabilisatoren als Polymerisationsinhibitoren von substituierten Cyclotetrasiloxanen
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
ATE339968T1 (de) Verwendung von mglur5 antagonists zur herstellung von medikamenten zur behandlung von empfindlichen x syndrome, autismus und geistiger zurückgebliebenheit
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
TR199901730T2 (xx) �ift halkal� karboksamidler ve bunlar�n terap�tik kullan�m�
DE60118956D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE222764T1 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties